# Arterial Remodeling Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arterial-remodeling-technologies-s-a

- Industry: Biotechnology
- Headquarters: Paris, France
- Website: www.art-stent.com
- Total disclosed funding: $12M
- Latest round: Series C (Jan 7, 2014)
- Investors on record: 5

## About

Arterial Remodeling Technologies S.A. specializes in innovative medical technologies aimed at enhancing vascular treatments, providing solutions for improved patient outcomes in the field of cardiovascular health.Founded in 2001 and headquartered in Paris, France, Arterial Remodeling Technologies S.A. focuses on developing advanced stenting solutions. The company has not undergone any noted pivots or structural changes since its inception. The firm has completed a total of 4 deals, with its most recent funding round occurring on January 7, 2014. In this round, Arterial Remodeling Technologies S.A. secured EUR 4 million through a Series C investment led by CDC Entreprises, along with participation from existing investors such as Amundi Real Estate and new investors including Nord Capital and Turenne Groupe. The total amount raised by the firm has reached EUR 4.063 million, reflecting a current company valuation of EUR 22.739 million.The primary offering of Arterial Remodeling Technologies S.A. is centered around the art-stent.com digital platform, which provides domain name resources and information related to the sale of the art-stent.com domain. This domain is currently listed for sale at an asking price of EUR 525, aimed at individuals and businesses needing a digital presence for branding or project purposes. The service appeals to startups, entrepreneurs, and established companies looking to enhance their online visibility across a global market without geographical restrictions.The revenue model of Arterial Remodeling Technologies S.A. is focused on the sale of the art-stent.com domain name, facilitated through a domain parking service provided by Sedo. The transactions are structured to be direct-to-consumer, allowing interested buyers to negotiate and purchase the domain at the listed price. Specific pricing plans or additional services are not offered, emphasizing the straightforward nature of the sales model targeting a diverse clientele seeking digital assets for various uses.Arterial Remodeling Technologies S.A. aims to leverage its most recent Series C funding of EUR 4 million to support potential expansion efforts. While specific upcoming products have not been detailed, the company may explore opportunities for new offerings in the medical technology sector. Additionally, there are plans to strengthen its market presence, although specific regions for expansion have not been disclosed. The recent funding will likely facilitate these initiatives, enabling the firm to pursue growth strategies aligned with its operational goals.

## Funding rounds

- Series C, Jan 7, 2014, $5.5M — Matignon Investissement et Gestion, CDC Entreprises, Turenne Groupe, Amundi, Nord Capital Partenaires
- Series B, Oct 14, 2010, $6.1M — Matignon Investissement et Gestion, CDC Entreprises, Amundi

## Investors

- Matignon Investissement et Gestion (https://capitalatlas.ai/funds/matignon-investissement-et-gestion) — Series B, Series C
- CDC Entreprises — Series B, Series C
- Amundi (https://capitalatlas.ai/funds/amundi) — Series B, Series C
- Turenne Groupe (https://capitalatlas.ai/funds/turenne-groupe) — Series C
- Nord Capital Partenaires (https://capitalatlas.ai/funds/nord-capital-partenaires) — Series C